Lucintel's latest market report analyzed that liquid biopsyprovidesattractive opportunities in reference laboratories, hospitals and physician laboratories, and academic and research centers. The liquid biopsymarket is expected to reach $10.4 billion by 2027 with a CAGR of 17%. In this market, circulating tumor DNA (ctDNA)is the largest segment by circulating biomarker, whereas therapy selection is the largest segment by clinical application. Theusage of methylation-specific polymerase chain reaction (MS-PCR) liquid biopsy technology and the emergence of hybrid ctDNA and CTC target selector provides strategic growth path in this market.
Download Brochure of this report by clicking on https://www.lucintel.com/liquid-biopsy-market.aspx
Based on circulating biomarker, the liquid biopsymarket is segmented intocirculating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other biomarkers.Lucintel forecasts that the circulating tumor DNA (ctDNA)market accounted for the largest share of the market in 2020 and is also expected to witness the highest growth over the forecast period due to increasing use of ctDNA biomarkers in next-generation sequencing (NGS) technologies for detecting diseases in real time and in early stage.
Browse in-depth TOC on “Liquid Biopsy Market”
129 – Tables
163 – Figures
264 – Pages
The liquid biopsy market is marked by the presence of several big and small players. Some of the prominent players offering liquid biopsy include Guardant, Bio-Rad Laboratories, Qaigen, MDxHealth, Myriad Genetics, Biocept, Roche, Illumina, and Thermofisher.
Request Sample Report:
https://www.lucintel.com/liquid-biopsy-market.aspx
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.